KNSA
NASDAQ 已收盘Kiniksa Pharmaceuticals International,
93.54 USD
▼-1.52-1.59%
盘后 95.85 0.00%
2026-11-19
市值
$7.43B
市盈率
71.46
EPS
1.32
股息率
—
52 周区间
37.02 – 99.31
成交量
427.53K
Beta
0.08
目标价
111.57
52W 低 37.0252W 高 99.31
价格走势
公司简介
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericard...